The global non-invasive cancer diagnostics market was valued at USD 80.9 billion in 2025 and is expected to reach USD 85.8 billion in 2026. By 2033, the market is projected to expand to USD 139.1 billion, registering a 7.1% CAGR from 2026 to 2033. North America led the global market in 2025, accounting for a 41.2% revenue share. Market expansion is being supported by the rising...